These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18460270)

  • 21. [Transition in pediatric rheumatology-experiences from the pediatric rheumatism center Sankt Augustin].
    Klein A; Olbert F; Wintrich S; Lutz-Wiegers V; Horneff G
    Z Rheumatol; 2018 Oct; 77(8):677-684. PubMed ID: 30043177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Childhood quality of life in the changing landscape of pediatric rheumatology.
    Reiff A
    J Pediatr (Rio J); 2008; 84(4):285-8. PubMed ID: 18688556
    [No Abstract]   [Full Text] [Related]  

  • 23. Current role for spa therapy in rheumatology.
    Forestier R; Erol-Forestier FB; Francon A
    Joint Bone Spine; 2017 Jan; 84(1):9-13. PubMed ID: 27282090
    [No Abstract]   [Full Text] [Related]  

  • 24. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening).
    Cuadros EN; Calzada-Hernández J; Clemente D; Martín SG; Silveira LF; Lirola-Cruz MJ; Tagarro A; Lovillo MC; Rueda RMA; López AL; Aritziturri MS; Calvo C
    Eur J Pediatr; 2022 Jun; 181(6):2343-2354. PubMed ID: 35258699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases.
    Ringold S; Nigrovic PA; Feldman BM; Tomlinson GA; von Scheven E; Wallace CA; Huber AM; Schanberg LE; Li SC; Weiss PF; Fuhlbrigge RC; Morgan EM; Kimura Y
    Arthritis Rheumatol; 2018 May; 70(5):669-678. PubMed ID: 29333701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome Measures in Pediatric Rheumatic Disease.
    Ringold S; Consolaro A; Ardoin SP
    Rheum Dis Clin North Am; 2021 Nov; 47(4):655-668. PubMed ID: 34635297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in pediatric rheumatology: January to March 2019.
    Kumar Patra P; Zaffar Banday A; Singh S
    Int J Rheum Dis; 2019 Jul; 22(7):1327-1330. PubMed ID: 31245911
    [No Abstract]   [Full Text] [Related]  

  • 28. Criteria to define response to therapy in paediatric rheumatic diseases.
    Ruperto N; Pistorio A; Ravelli A; Hasija R; Guseinova D; Filocamo G; Demirkaya E; Malattia C; Martini A;
    Eur J Clin Pharmacol; 2011 May; 67 Suppl 1():125-31. PubMed ID: 21103985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases.
    Manolis AS; Tzioufas AG
    Curr Vasc Pharmacol; 2020; 18(6):533-537. PubMed ID: 32693768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [What's new in infantile and adolescent rheumatology? Report of the 13th Anniversary of the Working Group on Infantile and Adolescent Rheumatology in Halle from 14 to 16 November 2003].
    Horneff G
    Z Rheumatol; 2005 Feb; 64(1):42-7. PubMed ID: 15756500
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence.
    Rodriguez MM; Wagner-Weiner L
    Pediatr Ann; 2017 Jan; 46(1):e19-e24. PubMed ID: 28079914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based use of methotrexate in children with rheumatic diseases: a consensus statement of the Working Groups Pediatric Rheumatology Germany (AGKJR) and Pediatric Rheumatology Austria.
    Niehues T; Horneff G; Michels H; Höck MS; Schuchmann L; ;
    Rheumatol Int; 2005 Apr; 25(3):169-78. PubMed ID: 15688190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum calprotectin: review of its usefulness and validity in paediatric rheumatic diseases.
    Mariani A; Marsili M; Nozzi M; Faricelli R; Chiarelli F; Breda L
    Clin Exp Rheumatol; 2015; 33(1):109-14. PubMed ID: 25535818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of exercise training in patients with pediatric rheumatic diseases.
    Gualano B; Pinto AL; Perondi MB; Roschel H; Sallum AM; Hayashi AP; Solis MY; Silva CA
    Rev Bras Reumatol; 2011; 51(5):490-6. PubMed ID: 21953000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric rheumatology in Southeast Asia: insights from the Singapore experience.
    Arkachaisri T
    Curr Rheumatol Rep; 2011 Apr; 13(2):117-22. PubMed ID: 21181313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
    Winthrop KL; Weinblatt ME; Bathon J; Burmester GR; Mease PJ; Crofford L; Bykerk V; Dougados M; Rosenbaum JT; Mariette X; Sieper J; Melchers F; Cronstein BN; Breedveld FC; Kalden J; Smolen JS; Furst D
    Ann Rheum Dis; 2020 Jan; 79(1):88-93. PubMed ID: 31662322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
    Giacomelli R; Afeltra A; Alunno A; Baldini C; Bartoloni-Bocci E; Berardicurti O; Carubbi F; Cauli A; Cervera R; Ciccia F; Cipriani P; Conti F; De Vita S; Di Benedetto P; Doria A; Drosos AA; Favalli EG; Gandolfo S; Gatto M; Grembiale RD; Liakouli V; Lories R; Lubrano E; Lunardi C; Margiotta DPE; Massaro L; Meroni P; Minniti A; Navarini L; Pendolino M; Perosa F; Pers JO; Prete M; Priori R; Puppo F; Quartuccio L; Ruffatti A; Ruscitti P; Russo B; Sarzi-Puttini P; Shoenfeld Y; Somarakis GA; Spinelli FR; Tinazzi E; Triolo G; Ursini F; Valentini G; Valesini G; Vettori S; Vitali C; Tzioufas AG
    Autoimmun Rev; 2017 Sep; 16(9):911-924. PubMed ID: 28705780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inequity of global healthcare in pediatric rheumatology.
    Vilaiyuk S; Hadef D; Hamdi W; Scott C; Slamang W; Foster HE; Lewandowski LB
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101983. PubMed ID: 39068104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.